Analyst Ratings for Larimar Therapeutics (LRMR)
LRMR Rating Summary
LRMR Price Target Summary
- Highest: $26.00 (Guggenheim)
- Lowest: $7.00 (Baird)
- Average: $15.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.67 (+200.1%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$15.67 (+200.1%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/5/2026 | Leerink Partners | Joseph Schwartz | New Coverage | Outperform (N/A) |
12.00 (N/A) |
3.47 (5.22) |
50.43% | Details |
| 1/29/2025 | Truist Securities » Updated 8/14/2025 |
Joon Lee | New Coverage | Buy (N/A) |
18.00 (N/A) |
3.48 (5.22) |
50% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
